Search
for
Sort by
Research 451–480 of 1000+
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Systemic-Onset Juvenile Idiopathic Arthritis with unusual Cutaneous Manifestation and peripheral eosinophilia: Case Report
- Therapeutic Potential of Stem Cells in Follicle Regeneration
- Stem Cell Therapy for Burns: Story so Far
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Integrating Psychological Support and Topical Therapy for the Effective Management of Stress-Induced Alopecia Areata: A Case Report
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved]
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Genotype Triad for HOTAIR rs10783618, LINC-ROR rs1942347, and MALAT1 rs3200401 as Molecular Markers in Systemic Lupus Erythematous
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- The JAK/STAT signaling pathway: from bench to clinic
- Methotrexate in dermatology
- Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review
- [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].